Cohorts transplanted with Prmt1 knockdown leukemia cells exhibited increased disease latency and a reduced penetrance compared with the scramble control (log-rank test p < 0.0001) (Figures 1I, S1F, and S1G). This evidence concerns the gene PRMT1 and leukemia.